Hancock Whitney’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,398
| Closed | -$209K | – | 610 |
|
|
2024
Q1 | $209K | Hold |
2,398
| – | – | 0.01% | 612 |
|
|
2023
Q4 | $231K | Hold |
2,398
| – | – | 0.01% | 595 |
|
|
2023
Q3 | $212K | Hold |
2,398
| – | – | 0.01% | 587 |
|
|
2023
Q2 | $208K | Sell |
2,398
-132
| -5% | -$11.5K | 0.01% | 595 |
|
|
2023
Q1 | $246K | Buy |
2,530
+20
| +0.8% | +$1.95K | 0.01% | 575 |
|
|
2022
Q4 | $260K | Hold |
2,510
| – | – | 0.01% | 560 |
|
|
2022
Q3 | $213K | Hold |
2,510
| – | – | 0.01% | 581 |
|
|
2022
Q2 | $208K | Buy |
+2,510
| New | +$208K | 0.01% | 608 |
|
|
2022
Q1 | – | Sell |
-2,510
| Closed | -$222K | – | 690 |
|
|
2021
Q4 | $222K | Sell |
2,510
-80
| -3% | -$7.08K | 0.01% | 649 |
|
|
2021
Q3 | $200K | Sell |
2,590
-458
| -15% | -$35.4K | 0.01% | 652 |
|
|
2021
Q2 | $254K | Buy |
3,048
+69
| +2% | +$5.75K | 0.01% | 717 |
|
|
2021
Q1 | $225K | Sell |
2,979
-461
| -13% | -$34.8K | 0.01% | 716 |
|
|
2020
Q4 | $302K | Sell |
3,440
-208
| -6% | -$18.3K | 0.01% | 642 |
|
|
2020
Q3 | $278K | Sell |
3,648
-72
| -2% | -$5.49K | 0.01% | 647 |
|
|
2020
Q2 | $459K | Sell |
3,720
-307
| -8% | -$37.9K | 0.02% | 527 |
|
|
2020
Q1 | $340K | Buy |
4,027
+92
| +2% | +$7.77K | 0.01% | 600 |
|
|
2019
Q4 | $333K | Sell |
3,935
-899
| -19% | -$76.1K | 0.01% | 657 |
|
|
2019
Q3 | $326K | Sell |
4,834
-146
| -3% | -$9.85K | 0.01% | 676 |
|
|
2019
Q2 | $427K | Sell |
4,980
-116
| -2% | -$9.95K | 0.01% | 650 |
|
|
2019
Q1 | $453K | Sell |
5,096
-1,357
| -21% | -$121K | 0.01% | 643 |
|
|
2018
Q4 | $549K | Sell |
6,453
-453
| -7% | -$38.5K | 0.02% | 545 |
|
|
2018
Q3 | $670K | Buy |
+6,906
| New | +$670K | 0.02% | 575 |
|